[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL189614A0 - Pharmaceutical compositions of telmisartan - Google Patents

Pharmaceutical compositions of telmisartan

Info

Publication number
IL189614A0
IL189614A0 IL189614A IL18961408A IL189614A0 IL 189614 A0 IL189614 A0 IL 189614A0 IL 189614 A IL189614 A IL 189614A IL 18961408 A IL18961408 A IL 18961408A IL 189614 A0 IL189614 A0 IL 189614A0
Authority
IL
Israel
Prior art keywords
telmisartan
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL189614A
Original Assignee
Teva Pharma
Kolatkar Gershon
Zisman Erela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Kolatkar Gershon, Zisman Erela filed Critical Teva Pharma
Publication of IL189614A0 publication Critical patent/IL189614A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL189614A 2005-11-22 2008-02-19 Pharmaceutical compositions of telmisartan IL189614A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/042700 WO2007061415A1 (en) 2005-11-22 2005-11-22 Pharmaceutical compositions of telmisartan

Publications (1)

Publication Number Publication Date
IL189614A0 true IL189614A0 (en) 2008-06-05

Family

ID=36645450

Family Applications (1)

Application Number Title Priority Date Filing Date
IL189614A IL189614A0 (en) 2005-11-22 2008-02-19 Pharmaceutical compositions of telmisartan

Country Status (6)

Country Link
JP (1) JP2009515956A (en)
CN (1) CN101312714A (en)
AU (1) AU2005338461A1 (en)
CA (1) CA2623018A1 (en)
IL (1) IL189614A0 (en)
WO (1) WO2007061415A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637078B2 (en) * 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
US20090048317A1 (en) * 2007-08-01 2009-02-19 Michael Fox Formulations of candesartan
CZ301070B6 (en) * 2008-07-31 2009-10-29 Zentiva, A. S. Telmisartan tablets
CZ301299B6 (en) * 2008-11-24 2010-01-06 Zentiva, A.S. Solid pharmaceutical composition with atorvastatin and telmisartan active ingredients
TWI564008B (en) 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 Formulation for solubility enhancement of poorly soluble drugs
CN102552161B (en) * 2010-12-28 2016-06-22 上海中西制药有限公司 The preparation method of a kind of pharmaceutical solid preparation and gained pharmaceutical solid preparation
CN102532033A (en) * 2012-02-29 2012-07-04 江西杏林白马药业有限公司 Telmisartan salifying process
CN104869983A (en) * 2012-12-21 2015-08-26 泰华制药工业有限公司 Transmucosal delivery of glatiramer acetate
WO2014119767A1 (en) * 2013-01-31 2014-08-07 沢井製薬株式会社 Multilayer tablet containing telmisartan and hydrochlorothiazide
JP6218664B2 (en) * 2013-04-04 2017-10-25 沢井製薬株式会社 Telmisartan-containing tablets
CN104688696B (en) * 2013-12-04 2017-12-19 长春海悦药业股份有限公司 A kind of pharmaceutical composition containing candesartan Cilexetil
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
JP5871294B1 (en) * 2015-02-27 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Immediate release oral tablets
WO2019130049A1 (en) 2017-12-29 2019-07-04 Grünenthal GmbH Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain
CN110934848B (en) * 2019-12-20 2022-02-15 江西杏林白马药业股份有限公司 Telmisartan capsule and preparation method thereof
CN115245497A (en) * 2021-04-26 2022-10-28 武汉伯睿科医药科技有限公司 Telmisartan capsule and preparation process thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA007614B1 (en) * 2002-01-16 2006-12-29 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Bilayer pharmaceutical tablet and method for producing thereof
DE10244681A1 (en) * 2002-09-24 2004-04-08 Boehringer Ingelheim International Gmbh New solid telmisartan-containing pharmaceutical formulations and their preparation

Also Published As

Publication number Publication date
CA2623018A1 (en) 2007-05-31
CN101312714A (en) 2008-11-26
AU2005338461A1 (en) 2007-05-31
JP2009515956A (en) 2009-04-16
WO2007061415A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
IL189614A0 (en) Pharmaceutical compositions of telmisartan
EP2001498A4 (en) Pharmaceutical compositions
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
EP2025337A4 (en) External pharmaceutical composition
EP2005959A4 (en) External pharmaceutical composition
ZA200900347B (en) Preparation of pharmaceutical compositions
PL2005958T3 (en) External pharmaceutical composition
PL2124556T3 (en) Pharmaceutical compositions
GB0513692D0 (en) Novel pharmaceutical compositions
IL195541A0 (en) Pharmaceutical compositions of memantine
EP2222313A4 (en) Pharmaceutical compositions
IL188352A0 (en) Pharmaceutical compositions
IL200885A (en) Substituted mannich-based compounds and pharmaceutical compositions comprising such
ZA200804103B (en) Pharmaceutical compositions
GB0610322D0 (en) Novel pharmaceutical compositions
GB0608724D0 (en) Novel Pharmaceutical Compositions
EP1971327A4 (en) Pharmaceutical compositions of ilaprazole
EP2146695A4 (en) Pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions
GB0707127D0 (en) Pharmaceutical compositions
IL198835A0 (en) Pharmaceutical compositions of memantine
EP1845944A4 (en) Pharmaceutical compositions
GB0522045D0 (en) Pharmaceutical compositions
ZA200803566B (en) Pharmaceutical compositions